Zurcher Kantonalbank Zurich Cantonalbank Has $3.57 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Zurcher Kantonalbank Zurich Cantonalbank trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 14.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 38,833 shares of the medical device company's stock after selling 6,428 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Cooper Companies were worth $3,570,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AlphaQuest LLC grew its position in Cooper Companies by 2,137.2% during the fourth quarter. AlphaQuest LLC now owns 13,938 shares of the medical device company's stock valued at $1,281,000 after purchasing an additional 13,315 shares in the last quarter. OFI Invest Asset Management acquired a new position in shares of Cooper Companies in the fourth quarter worth $34,000. Rialto Wealth Management LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth $215,000. Machina Capital S.A.S. boosted its position in Cooper Companies by 363.5% during the fourth quarter. Machina Capital S.A.S. now owns 16,936 shares of the medical device company's stock valued at $1,557,000 after purchasing an additional 13,282 shares during the last quarter. Finally, Andra AP fonden purchased a new position in Cooper Companies in the fourth quarter valued at about $1,030,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded up $0.08 during trading on Wednesday, reaching $80.12. The company's stock had a trading volume of 1,894,036 shares, compared to its average volume of 1,271,111. The business's fifty day moving average price is $90.68 and its 200-day moving average price is $98.56. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The firm has a market cap of $16.02 billion, a price-to-earnings ratio of 41.08, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on COO shares. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.